American Medical Student Association to Release Scorecard on Conflict-of-interest Policies; Virtual Press Conference Scheduled for Thursday, March 8

Share Article

On Thursday, March 8, 2012, the American Medical Student Association (AMSA) will release the 2011-2012 AMSA PharmFree Scorecard, an evaluation of conflict-of-interest policies at all U.S. medical colleges and colleges of osteopathic medicine.

On Thursday, March 8, 2012, the American Medical Student Association (AMSA) will release the 2011-2012 AMSA PharmFree Scorecard, an evaluation of conflict-of-interest policies at all U.S. medical colleges and colleges of osteopathic medicine.

The AMSA PharmFree Scorecard, now in its fifth year, uses letter grades to assess medical schools’ performances in eleven potential areas of conflict, including gifts and meals from industry to doctors, paid promotional speaking for industry, acceptance of free drug samples, interaction with sales representatives and industry-funded education. AMSA will also be releasing trend data.

When:                    
Thursday, March 8, 2012
11 am EST/ 8 am PST

Location:                    
Hyatt Regency Houston
1200 Louisiana Street
Houston, Texas
Press must check in at AMSA registration desk

Toll Free Access Number:    
(559) 726-1000
Participant Passcode: 161471#

Webex Login:    
Meeting Number: 570 593 197
Meeting Password: Web1234
Log in here.

The 2011-2012 AMSA PharmFree Scorecard will be updated and posted on http://www.amsascorecard.org on March 8, 2012.

About the American Medical Student Association
AMSA is the oldest and largest independent association of physicians-in-training in the United States. Founded in 1950, AMSA is a student-governed, nonprofit organization committed to representing the concerns of physicians-in-training. To learn more about AMSA, our strategic priorities, or joining the organization, please visit us online at http://www.amsa.org.

The 2011-2012 AMSA PharmFree Scorecard is made possible by a grant from the state Attorney General Consumer and Prescriber Education Grant Program which is funded by the multi-state settlement of consumer fraud claims regarding the marketing of the prescription drug Neurontin.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Visit website